Immunological and toxicological implications of short-term studies in animals of pharmaceutical aerosol delivery to the lungs: Relevance to humans

Critical Reviews in Therapeutic Drug Carrier Systems

Volumn 18, Issue 4, 2001, Pages 387-431

  Hickey, Anthony J ^a   Garcia Contreras, Lucila ^a  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

Aerosols; Animal models; Drug delivery; Immunology; Toxicology

Indexed keywords

ANTIOXIDANT; ARACHIDONIC ACID; COMPLEMENT; ENZYME; GROWTH FACTOR; MONOKINE; NUCLEIC ACID; PEPTIDE DERIVATIVE; PROTEIN DERIVATIVE; XENOBIOTIC AGENT;

AERATION; AEROSOL; AIRWAY CONDUCTANCE; ANIMAL EXPERIMENT; ANIMAL MODEL; BODY PLETHYSMOGRAPHY; BREATHING MECHANICS; DRUG DELIVERY SYSTEM; DRUG INSTILLATION; HUMAN; IMMUNOLOGY; INHALATION; LUNG; LUNG FUNCTION; LUNG LOBE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PHARMACODYNAMICS; PNEUMOTACHYGRAPHY; POSITIVE END EXPIRATORY PRESSURE; RAT; RESPIRATORY EPITHELIUM; RESPIRATORY FUNCTION; REVIEW; TOXICOLOGY;

EID: 0034791636     PISSN: 07434863     EISSN: None     Source Type: Journal    
DOI: 10.1615/critrevtherdrugcarriersyst.v18.i4.20     Document Type: Review

References (129)

1. 1-antitrypsin: Use of the epithelial surface of the lower respiratory tract to administer proteins of therapeutic importance
2. Aerosol gene delivery in vivo
3. Insulin inhalation: Its potential as a nonparenteral method of administration
4. Medical devices for the delivery of therapeutic aerosols to the lungs
5. Aerosols for delivery of therapeutic and diagnostic agents to the respiratory tract
6. Drug targeting to the lung: Chemical and biochemical considerations
7. Drug metabolism and enzyme kinetics in the lung
8. Prodrugs for pulmonary drug targeting
9. Metabolic characteristics of the respiratory tract
10. Drug properties affecting aerosol behavior
11. Pharmaceutical dry powder aerosols: Correlation of powder properties with dose delivery and implications for pharmacodynamic effect
12. Nebulizer delivery of oligosaccharide solution aerosols
13. Aerosol delivery of muramyl dipeptide to rodent lung
14. Efficacy of rifampicin-poly(lactide-co-glycolide) microspheres in treating tuberculosis
15. Inhalation exposure systems
16. Animal models
17. Airway structures: Tracheobronchial airway structure as revealed by casting techniques
18. Small airways and terminal units: Comparative subgross anatomy of lungs
19. Morphometric characteristics of cells in the alveolar region of mammalian lungs
20. Morphologic features of airway surface epithelial cells and glands
21. Histochemical properties of the respiratory tract epithelium in different species
22. Comparative morphologic features of bronchiolar epithelial cells: The Clara cell
23. Ultrastructural criteria for identification of mast cells and basophils in humans, guinea pigs, and mice
24. Crohn's disease: Transmission electron microscopic studies. II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and the microvasculature
25. Cell turnover in the lung
26. Pulmonary vasculature and nerves: Comparative morphologic features of the pulmonary vasculature in mammals
27. Steady-state vascular responses to hypoxia in isolated lungs of five species
28. Ultrastruture of pulmonary lymphatic vessels
29. Recent progress in pulmonary innervation
30. Mathematical expression of the effects of changes in body size on pulmonary function and structure
31. Scaling of respiratory variables in mammals
32. Mechanism that determine functional residual capacity in different mammalian species
33. Surgery of laboratory animals
34. Respiratory dust retention in small animals
35. Similarity and dimensional analysis evaluation of aerosol deposition in the lungs of laboratory animals and man
36. Scaling theory for aerosol deposition in the lungs of different mammals
37. Species difference in aerosol deposition
38. Comparative toxicology of the respiratory tract
39. Experimental models and pulmonary antimicrobial defenses
40. Differences in phagocytosis and killing by alveolar macrophages from humans rabbits rats and hamsters
41. Comparison of tracheal mucous in rats guinea pigs rabbits and dogs
42. Studies on the mechanism of toxicity and of development of tolerance to the pulmonary toxin alpha-naphthylthiourea
43. Paraquat
44. Prediction of drug residence times in regions of the human respiratory tract following aerosol inhalation
45. Pulmonary targeting of liposomal triamcinolone acetonide phosphate
46. Drugs administered directly into the respiratory tract: Modeling of the duration of effective drug levels
47. Relative bioavailability of sodium cromoglycate to the lung following inhalation using urinary excretion
48. Modes to achieve topical selectivity of inhaled glucocorticosteroids: Focus on budesonide
49. Fluticosone propionate: Pharmacokinetic and pharmacodynamic implications of different aerosol delivery systems
50. Glucocorticoid receptors
51. Pulmonary function testing
52. Static lung volumes: Functional residual capacity residual volume and total lung capacity
53. Use of bronchoalveolar lavage to detect lung damage
54. Use of bronchoalveolar lavage to detect lung damage
55. New approaches for the evaluation of pulmonary toxicology: Bronchoalveolar lavage fluid analysis
56. Influence of local cationic anesthetics on the metabolism and ultrastructure of human alveolar macrophages
57. Bronchoalveolar lavage
58. Bronchoalveolar lavage for the preparation of free lung cells: Technique and complications
59. Safety of fiberoptic bronchoalveolar lavage in evaluation of interstitial lung disease
60. An in vivo hamster bioassay to assess the toxicity of particles in the lungs
61. A comparison of in vitro and in vivo toxicity of mineral dusts
62. Bronchopulmonary lavage of small laboratory animals
63. The short-term cellular and biochemical response of the lung to toxic dusts: An in vivo toxicity test
64. The effect of quartz administered by intratracheal instillation on the rat lung
65. The pulmonary toxicity of an ash sample from the Mt. St. Helens volcano
66. Assessment of progression of asbestosis in the sheep model by bronchoalveolar lavage and pulmonary function tests
67. Bronchoalveolar lavage
68. Effect of chloroquine on phagolysosomal fusion in cultured guinea pig macrophages: Implications for drug delivery
69. Bronchoalveolar cells from sarcoid patients demonstrate enhanced antigen presentation
70. Enhanced alveolar macrophage-mediated antigen-induced T-lymphocyte proliferation in sarcoidosis
71. Normal human alveolar macrophages obtained by bronchoalveolar lavage have a limited capacity to release interleukin-1
72. Involvement of immunoglobulin E in the secretory processes of alveolar macrophages from asthmatic patients
73. Human lung macrophages induce histamine release from basophils and mast cells
74. Human granulocyte elastase further delineation of its role in connective tissue damage
75. Elastolytic activity in pulmonary lavage fluid from patients with adult respiratory-distress syndrome
76. Spontaneous release of interleukin-2 by lung T-lymphocytes in active pulmonary sarcoidosis
77. Role of Interleukin-2 release by lung T-cells in active pulmonary sarcoidosis
78. Cytotoxic properties of the eosinophil major basic protein
79. Generation and metabolism of 5-lipoxygenase pathway leukotrienes by human eosinophils: Predominant production of leukotriene C4
80. Bleomycin-induced pulmonary fibrosis in the rat: Inhibition by indomethacin
81. Mast cells in bronchoalveolar lumen of patients with bronchial asthma
82. The mast cell
83. Mast cells mediators and asthma
84. Comparative studies of human basophils and mast cells
85. Structure and function of the chemical mediators of mast cells
86. Deficiency of vitamin E in the alveolar fluid of cigarette smokers. Influence on alveolar macrophage cytotoxicity
87. Plasma proteins of the bronchoalveolar surface of the lungs of smokers and nonsmokers
88. Glutathione is present in normal alveolar epithelial lining fluid in sufficient concentration to provide antioxidant protection to lung parenchymal cells
89. Ceruloplasmin: Increased serum concentration and impared antioxidant activity in cigarette smokers and ability to prevent suppression of elastase inhibitory capacity of alpha-1-proteinase inhibitor
90. Effects of the long term depletion of reduced glutathione in mice administered L-buthionine-S R-sulfoximine
91. Oxygen toxicity: Loss of lung macrophage function without metabolic depletion
92. Comparative removal of ascorbic acid on other airway substances by sequential bronchoalveolar lavages
93. Bronchoconstriction effects of leukotriene C in humans
94. Biologically active complement (C5)-derived peptides and their relevance to disease
95. Complement fragments alveolar macrophages and alveolitis
96. Analysis of proteins and respiratory cells obtained from human lungs by bronchial lavage
97. Complement biosynthesis by human bronchoalveolar macrophages
98. Complement metabolism: Cellular and humoral regulation
99. Biosynthesis of the first component of complement by human fibroblasts
100. The pulmonary response of C5 sufficient and deficient mice to pseudomonas aeruginosa
101. Chemotaxis of human and murine mononuclear phagocytes
102. Modulation of alveolar macrophages-driven fibroblast proliferation by alternative macrophage mediators
103. Fibronectin in human bronchopulmonary lavage fluid. Elevation in patients with interstitial lung disease
104. 2 inhalation
105. 2-macroglobulin a physiological regulator of proteinase activity
106. Alveolar protein accumulation. A sensitive indicator of low level oxidant toxicity
107. Ultrastructural immunoperoxidase demonstration of autologous albumin in the alveolar capillary membrane and in the alveolar lining material in normal rats
108. HPLC analyses of lavage fluid constituents following environmental insults
109. Pneumotoxicity and pulmonary clearance of different welding fumes after intratracheal instillation in the rat
110. Pulmonary toxicity of components of textile paint linked to ardystil syndrome: Intratracheal administration in hamsters
111. A comparison of the inflammatory response of the lung to inhaled versus instilled particles in F344 rats
112. Ethical Scores for animal procedures
113. A comparison of existing and proposed inhalation systems for dosing dogs from pressurized metered dose inhalers